Logo image
A novel binding pocket of cyclin-dependent kinase 2
Journal article   Open access   Peer reviewed

A novel binding pocket of cyclin-dependent kinase 2

Hao Chen, Rachel Van Duyne, Naigong Zhang, Fatah Kashanchi and Chen Zeng
Proteins, structure, function, and bioinformatics, v 74(1), pp 122-132
01 Jan 2009
PMID: 18615713
url
https://europepmc.org/articles/pmc4497517View

Abstract

Biochemistry & Molecular Biology Biophysics Life Sciences & Biomedicine Science & Technology
The cyclin-dependent kinase 2 (cdk2) is a serine/threonine protein kinase that plays a key role in the cell cycle control system of all eukaryotic organisms. It has been a much studied drug target for potential anticancer therapy. Most cdk2 inhibitors in clinical development target almost exclusively the catalytic ATP-binding pocket of cdk2. However, several five amino-acid peptide inhibitors that are directed towards a noncatalytic binding pocket of cdk2 are reported here. Upon binding to this new pocket located at the cdk2 and cyclin interface, these peptide inhibitors are found to disrupt the cdk2/cyclin E complex partially and diminish its kinase activity in vitro.

Metrics

13 Record Views
20 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Biochemistry & Molecular Biology
Biophysics
Logo image